What is Reselute?
Reselute Medical operates at the intersection of advanced orthopedics and localized pharmacology. The company is primarily recognized for the development of the Reselution Tibial Intramedullary Fixation System, a sophisticated medical device designed to address the high-risk complications associated with orthopedic-related infections. By integrating structural bone fixation with sustained antibiotic delivery, Reselute provides a dual-action solution that streamlines surgical procedures for orthopedic surgeons. This innovation is specifically engineered to mitigate the risks inherent in high-energy fracture care, positioning the company as a critical player in the medical device landscape. Their market position is defined by a commitment to improving patient outcomes through precision engineering and the reduction of post-operative infection rates, which remain a significant challenge in modern trauma surgery.
How much funding has Reselute raised?
Reselute has raised a total of $1M across 1 funding round:
Stock/Share Issuance
$1M
Stock/Share Issuance (2026): $1M, investors not publicly disclosed
Key Investors in Reselute
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Reselute?
Following this major enterprise-level funding, Reselute is expected to scale its manufacturing capabilities and expand its clinical trial footprint. The strategic deployment of this capital will likely focus on regulatory milestones and the commercialization of its flagship fixation system. As the company transitions from a development-stage entity to a commercial-ready medical technology provider, the focus will shift toward securing broader hospital network adoption and establishing long-term clinical efficacy data. Investors are closely monitoring the company's ability to disrupt the standard of care in fracture management, with future growth likely contingent on successful market penetration and the potential expansion of their antibiotic delivery platform into additional orthopedic applications.
See full Reselute company page
